The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans.
作者信息
Austin H, Hooper W C, Dilley A, Drews C, Renshaw M, Ellingsen D, Evatt B
机构信息
Division of AIDS, STD, Atlanta, GA, USA.
出版信息
Thromb Res. 1997 Jun 1;86(5):409-15. doi: 10.1016/s0049-3848(97)00086-8.
PMID:9211632
Abstract
摘要
相似文献
1
The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans.
Thromb Res. 1997 Jun 1;86(5):409-15. doi: 10.1016/s0049-3848(97)00086-8.
2
Relation of three genetic traits to venous thrombosis in an African-American population.
Am J Epidemiol. 1998 Jan 1;147(1):30-5. doi: 10.1093/oxfordjournals.aje.a009363.
3
Inherited thrombophilia genes in minorities.
Genet Test. 1999;3(4):371-3. doi: 10.1089/gte.1999.3.371.
4
A homozygosity state for 20210A prothrombin variant in a young woman as cause of a deep venous thrombosis during pregnancy.
Eur J Haematol. 2000 Jul;65(1):80-1. doi: 10.1034/j.1600-0609.2000.9l140.x.
5
Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks.
Am J Hum Genet. 1997 Jan;60(1):229-30.
6
5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1611-21.
7
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity.
Blood. 2002 Jan 15;99(2):437-42. doi: 10.1182/blood.v99.2.437.
8
Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Am J Hematol. 2001 Jan;66(1):28-31. doi: 10.1002/1096-8652(200101)66:1<28::AID-AJH1003>3.0.CO;2-3.
9
10
Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
Thromb Haemost. 1997 Nov;78(5):1357-9.
引用本文的文献
1
Lack of Association of Methylenetetrahydrofolate Reductase Polymorphism with Breast Cancer Risk in Mali.
Genet Res (Camb). 2023 Jan 17;2023:4683831. doi: 10.1155/2023/4683831. eCollection 2023.
2
Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.
Blood Cells Mol Dis. 2006 Sep-Oct;37(2):100-6. doi: 10.1016/j.bcmd.2006.06.003. Epub 2006 Aug 2.
Zotero 插件